Literature DB >> 15723948

Mucosal wound healing in a rabbit model of subglottic stenosis: biochemical analysis of secretions.

Ryan C Branski1, Vlad C Sandulache, Joseph E Dohar, Patricia A Hebda.   

Abstract

OBJECTIVES: To build on work in laryngology and oral biology that suggests utility in the assay of secretions collected from wound sites as a predictive instrument to determine which infants will likely develop subglottic stenosis following endotracheal intubation and to document and describe the wound-healing process.
DESIGN: Prospective, randomized design. INTERVENTION: Laser-induced subglottic injury was established in 3 rabbits. Secretions were collected from the subglottic region at 6 time points from days 4 to 21 following injury and from 4 uninjured control airways. The secretions were then subjected to enzyme-linked immunoassays for interleukin 1 beta and prostaglandin E2.
SUBJECTS: Three adult New Zealand white rabbits. MAIN OUTCOME MEASURES: Interleukin 1 beta and prostaglandin E2 levels.
RESULTS: Measurable amounts of both mediators were obtained. Furthermore, different temporal patterns of expression were observed with interleukin 1 beta, showing increased levels on days 4 to 18, and with prostaglandin E2, showing increased levels on days 7 to 18. These results concur with emerging data regarding the role of each mediator in the wound-healing process.
CONCLUSION: Although in its infancy, the analysis of secretions collected from the site of injury in the subglottis may have utility in the management of patients following intubation-related trauma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723948     DOI: 10.1001/archotol.131.2.153

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  T-Helper 2 Lymphocyte Immunophenotype Is Associated With Iatrogenic Laryngotracheal Stenosis.

Authors:  Alexander T Hillel; Dacheng Ding; Idris Samad; Michael K Murphy; Kevin Motz
Journal:  Laryngoscope       Date:  2018-11-13       Impact factor: 3.325

2.  Subglottic stenosis examined as a fibrotic response to airway injury characterized by altered mucosal fibroblast activity.

Authors:  Tripti Singh; Vlad C Sandulache; Todd D Otteson; Mark Barsic; Edwin C Klein; Joseph E Dohar; Patricia A Hebda
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-02

3.  Cyclooxygenase-2 inhibition for the prevention of subglottic stenosis.

Authors:  Selma Cetin; Allison B Tobey; Vlad C Sandulache; Tianbing Yang; Mark Barsic; Yan Lin; Joseph E Dohar; Patricia A Hebda
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-10

4.  Vocal exercise may attenuate acute vocal fold inflammation.

Authors:  Katherine Verdolini Abbott; Nicole Y K Li; Ryan C Branski; Clark A Rosen; Elizabeth Grillo; Kimberly Steinhauer; Patricia A Hebda
Journal:  J Voice       Date:  2012-11       Impact factor: 2.009

5.  Acute and chronic changes in the subglottis induced by graded carbon dioxide laser injury in the rabbit airway.

Authors:  Todd D Otteson; Vlad Constantin Sandulache; Mark Barsic; Gregory M Disilvio; Patricia A Hebda; Joseph E Dohar
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-07

6.  Laryngotracheal Mucosal Surface Expression of Candidate Biomarkers in Idiopathic Subglottic Stenosis.

Authors:  Melissa M Liu; Kevin M Motz; Michael K Murphy; Linda X Yin; Dacheng Ding; Alexander Gelbard; Alexander T Hillel
Journal:  Laryngoscope       Date:  2020-05-05       Impact factor: 2.970

7.  In-vivo efficacy of biodegradable ultrahigh ductility Mg-Li-Zn alloy tracheal stents for pediatric airway obstruction.

Authors:  Jingyao Wu; Leila J Mady; Abhijit Roy; Ali Mübin Aral; Boeun Lee; Feng Zheng; Toma Catalin; Youngjae Chun; William R Wagner; Ke Yang; Humberto E Trejo Bittar; David Chi; Prashant N Kumta
Journal:  Commun Biol       Date:  2020-12-18

Review 8.  Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know?

Authors:  Ruth J Davis; Alexander T Hillel
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.